The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Next-generation sequencing (NGS) in an advanced hepatocellular carcinoma (HCC) cohort: Analyses of TP53 and CTNNB1.
 
Robin Kate Kelley
Consulting or Advisory Role - Acceleron Pharma; Lilly
Research Funding - Celgene (Inst); Exelixis (Inst); Lilly (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); Tekmira (Inst)
 
John Dozier Gordan
No Relationships to Disclose
 
Kimberley Evason
No Relationships to Disclose
 
Paige M. Bracci
No Relationships to Disclose
 
Nancy M. Joseph
No Relationships to Disclose
 
Andrea Grace Bocobo
No Relationships to Disclose
 
Blake K. Rosenthal
No Relationships to Disclose
 
Halla Sayed Nimeiri
No Relationships to Disclose
 
Alan P. Venook
Honoraria - Gilead Sciences
Consulting or Advisory Role - Gilead Sciences
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Onyx (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech; Halozyme; Merck Serono; Roche